Immunosuppressive treatment facilitates hepatic recompensation in patients with decompensated cirrhosis due to autoimmune hepatitis-a pilot study

被引:0
|
作者
Hofer, Benedikt [1 ,2 ,3 ,4 ]
Burghart, Lukas [5 ]
Treiber, Sonja [1 ]
Halilbasic, Emina [1 ,4 ]
Mandorfer, Mattias [1 ,2 ]
Trauner, Michael [1 ,4 ]
Reiberger, Thomas [1 ,2 ,3 ,4 ]
Staettermayer, Albert Friedrich [1 ,4 ]
机构
[1] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
[2] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna Hepat Hemodynam Lab, Vienna, Austria
[3] Med Univ Vienna, Christian Doppler Lab Portal Hypertens & Liver Fi, Vienna, Austria
[4] Vienna Gen Hosp, Rare Liver Dis RALID Ctr, ERN RARE LIVER, Vienna, Austria
[5] Klin Ottakring, Wiener Gesundheitsverbund, Vienna, Austria
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-183-YI
引用
收藏
页码:S341 / S342
页数:2
相关论文
共 50 条
  • [41] A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B
    Yingnan Huang
    Hao Wu
    Shengdi Wu
    Da Fu
    Yushui Ma
    Xizhong Shen
    Digestive Diseases and Sciences, 2013, 58 : 815 - 823
  • [42] A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B
    Huang, Yingnan
    Wu, Hao
    Wu, Shengdi
    Fu, Da
    Ma, Yushui
    Shen, Xizhong
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (03) : 815 - 823
  • [43] Treatment of patients with decompensated cirrhosis due to chronic hepatitis C: Results with a low accelerating dose regimen (LADR) of antiviral therapy.
    Everson, GT
    LIVER TRANSPLANTATION, 2005, 11 (07) : C37 - C37
  • [44] Effect of lamivudine treatment in patients with decompensated cirrhosis due to anti-HBe positive/HBeAg-negative chronic hepatitis B
    Nikolaidis, N
    Vassiliadis, T
    Giouleme, O
    Tziomalos, K
    Grammatikos, N
    Patsiaoura, K
    Orfanou-Koumerkeridou, E
    Balaska, A
    Eugenidis, N
    CLINICAL TRANSPLANTATION, 2005, 19 (03) : 321 - 326
  • [46] Refining Treatment Decisions in HCV-Infected Patients with Decompensated Cirrhosis: Frequency and Predictors of Recompensation with Direct-Acting Antiviral (DAA) Therapy
    Radhakrishnan, Kavita
    Dodge, Jennifer L.
    McKinney, Jeff
    Catalli, Lisa
    Straley, Stephanie
    Price, Jennifer C.
    Terrault, Norah
    HEPATOLOGY, 2018, 68 : 712A - 712A
  • [47] Effect of entecavir in the treatment of patients with hepatitis B virus-related compensated and decompensated cirrhosis
    Gai, Xiao-Dong
    Wu, Wei-Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (04) : 3908 - 3914
  • [48] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [49] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E877 - E882
  • [50] Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
    Czaja, AJ
    Lindor, KD
    GASTROENTEROLOGY, 2000, 119 (05) : 1312 - 1316